Hostname: page-component-6766d58669-76mfw Total loading time: 0 Render date: 2026-05-16T16:06:45.042Z Has data issue: false hasContentIssue false

Tranexamic acid – a useful drug in ENT surgery?

Published online by Cambridge University Press:  14 July 2014

P J Robb*
Affiliation:
Department of Otolaryngology, Epsom and St Helier University Hospitals, Epsom, UK
*
Address for correspondence: Mr Peter J Robb, Department of Otolaryngology, Epsom and St Helier University Hospitals, Epsom KT18 7EG, UK Fax: +44 1372 735 048 E-mail: peter.robb@esth.nhs.uk

Abstract

Background:

Tranexamic acid is a synthetic antifibrinolytic drug. It has been widely available for over 40 years, but only recently has it started to be used routinely in many surgical disciplines. For ENT surgeons, epistaxis and post-tonsillectomy bleeding contribute a significant proportion of the morbidity and emergency workload in a general ENT department. Published evidence indicates a potentially helpful role for tranexamic acid in managing epistaxis.

Results and conclusion:

To date, the benefits of tranexamic acid as a prophylactic treatment to reduce the rate and severity of post-tonsillectomy bleeding are less certain. Two recently published pilot studies looking at primary haemorrhage in children and secondary haemorrhage in adults following tonsillectomy suggest that further large, randomised trials should explore the efficacy of tranexamic acid in routine ENT surgery. There are potential reductions in patient morbidity and cost savings if tranexamic acid is found to be efficacious in larger trials.

Information

Type
Review Articles
Copyright
Copyright © JLO (1984) Limited 2014 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

Article purchase

Temporarily unavailable